Tim Smith

This new data indicated a necessity for clinical strategies made to handle unintentional pathogenic or likely pathogenic germline variants seen in tumor-only next-generation sequencing.

This new research letter highlights several trends in prescribing by both dermatologists and non-dermatologists from 2017 to 2020.

This new research indicates that while there are ongoing trials seeking to define which individuals with subsegmental PE may be surveilled, greater uptake of newer surveillance actions may necessitate more than passive diffusion.

In this Q&A interview with Dr. Rieder, he describes the biggest takeaways from his panel discussion on the mental health needs of dermatology patients.

The FDA has updated its list of UV wands, used to disinfect surfaces, to avoid due to potentially harmful levels of radiation exposure.

This segment of Dr. Eichenfield’s interview featured a discussion about Eichenfield’s response to the FDA’s approval of cantharadin 0.7%, or VP-102, for molluscum contagiosum.

In his latest recorded interview, Dr. Eichenfield described the use of VP-102, or cantharidin 0.7%, for molluscum contagiosum.

This new data highlights the lack of reliability with regard to medical information disseminated on social media platforms, and the frequency at which such information is observed.

This new data from China showed that both the duration of mask-wearing and greater use of facial cleansing may result in skin deterioration, though moisturizing products were found to have more positive effects.

This analysis demonstrated the efficacy of topical azelaic acid, though further randomized control trial evidence may be needed for an evaluation of the treatment on skin aging.

The results of this analysis indicated that while improvement was seen in both groups, slight dermoscopy score improvement was observed in those given a combination laser-minoxidil treatment compared to only minoxidil.

This new research further highlights the importance of addressing traffic pollution as an environmental justice issue, as it impacts pregnancies and leads to disparities in traffic-related exposure levels.

This new data indicates opportunities which may have been missed for initiation of fracture prevention for elderly individuals treated with oral corticosteroids.

This new research indicates a potentially-promising new way of addressing clinical management of prurigo nodularis.

This new data may need to be examined by health providers when they advise patients about treatment outcomes for increasing dosage, including those who could benefit from a higher dose of baricitinib.

In this interview segment, Dr. Lim further discussed findings from his team’s research into infrared radiation’s effects on the skin and the implications of these findings.

This interview featured a discussion with Dr. Lim on his team’s findings regarding the effects of infrared radiation on human skin.

Positive results from REMIX-1 and REMIX-2 on remilbrutinib could mean the beginning of a new class of chronic spontaneous urticaria therapy in about a decade.

This new data from the UK suggests possible opportunities for preventing anxiety and depression for those with eczema or psoriasis by addressing modifiable risk factors such as sleep.

This study’s findings demonstrate the necessity of risk factor identification for atopic-like dermatitis, as well as the importance of exploring alternative treatments for severe cases.

The new research in this study indicates that both types of food challenges may be equally useful when conducted by trained staff who use strict objective stop criteria.

These new findings suggest the COMSA parameters may have applicability for standardizing observational studies’ results for pediatric patients with asthma.

The data from this analysis indicates that for those with psoriasis, effective and long-term continuous control of the skin disease could diminish risk of CCVD risk.

The apparent risk increases for use of these medications over the past 2 decades suggests the global importance of health care reforms and focus on drug safety.

This expanded upon the limited data available on risks of precautionary allergen label food introduction for those with allergies, the results of which suggest new possibilities for future allergy management.

This interview with Dr. Chovatiya featured a discussion about new findings from a recent study on epidemiologic data on vitiligo in the US.

This new data indicates that dupilumab in this patient population had favorable efficacy and safety, though some unique concerns were risk of infection and eosinophilia.

The data from this new study may indicate home NBUVB treatment effectiveness and other benefits such as financial, convenience, and medical benefits.

This recent research indicates the necessity for clinicians to be aware of the higher autoimmune disease susceptibility of those with previous rotavirus-associated hospitalization.

In this interview with Dr. Gold, she describes her team’s recent findings from a phase 4 head-to-head study on risankizumab for psoriasis patients.